DocWire News Editors

DocwireNews

Hospital readmissions for infective endocarditis increased by stunning 436% from 2012 to 2017 in one surveyed region of the country hard-hit by the crisis, new research being presented at ACC.19 in New Orleans will show.The research team from Ohio State University Wexner Medical Center preformed a retrospective institutional review of admissions for infective endocarditis&ndash; bacteria buildup inside of heart valves or in the heart lining &mdash;during the years 2012 to 2017. They then looked at patient encounters for affected valve, management, microbiology and other factors.According to the results, there was a 101% increase in admissions for infective endocarditis and a 436% increase in endocarditis admissions related to intravenous drug use (P&lt;0.00001). There was also change in the type of admission, with 75% of patients being admitted for cardiology services dropping to 37% in 2017. There were also changes in treatment and management. There was also a significant increase in death rates: From 9% in 2012 to 25% in 2017.&ldquo;What&rsquo;s most striking is how quickly this problem got out of hand,&rdquo; said lead author Serena Day, MD, a cardiology fellow at The Ohio State University, in an ACC press release. &ldquo;Five years ago, this disease was very uncommon for us. Now, it&rsquo;s become so common that we can&rsquo;t keep up.&rdquo;The analysis also showed that 55% of patients were treated medically compared to 18% treated surgically (P&lt;0.0003). Dr. Day said that doctors are often hesitant to assign patients to surgery due to the high risk of reinfection due to injectable drug use&ldquo;There&rsquo;s really been a paradigm shift in how we treat these patients at our institution,&rdquo; Day added. &ldquo;Many of these patients continue to use, they continue to relapse, and they come back even sicker than they were before. This study underscores the fact that, without treating the addiction, these patients aren&rsquo;t going to get better. There has to be a comprehensive approach to treating this disease.&rdquo;The ACC press release went on to note that the hospital saw just 196 cases related to intravenous drug use in 2012, which increased to 395 cases related to intravenous drug use, with 177 cases implicating the drug use itself as the cause (about half of all cases). The press release went on to note that heroin was determined to be the killer in most of the drug-related cases, the use of which has increased dramatically in recent years to become a national health crisis. The National Safety Council reported that a person&rsquo;s likelihood from dying from an opioid overdose, for the first time, was higher than the likelihood of dying in a motor vehicle crash.

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Jordana Jampel

Glycan-Targeting Novel Vaccine Shows Promise for Vast Virus Protection

Infectious Disease

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Latest News

Endocarditis Spikes With Higher Opioid Use Levels

ACC 2019 Conference

Hospital readmissions for infective endocarditis increased by stunning 436% from 2012 to 2017 in one surveyed region of the country hard-hit by the crisis, new research being ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe